Medical and Pharmaceutical New Korean cancer tech finds mutations with only a few drops of blood In a clinical trial with blood from 83 patients, the test identified 100 per cent of EGFR gene mutations Joseph MortonFebruary 18, 2025
Health & Wellness Grail shares jump on partnership with Quest Diagnostics The test operates on the principle that cancers shed DNA into the bloodstream Joseph MortonFebruary 14, 2025
Medical and Pharmaceutical Scottish study finds biomarker blood biopsy testing can reduce lung cancer fatalities by 40% It was completed by the University of St Andrews and published in the PLOS One journal on Wednesday Rowan DunneJanuary 9, 2025
Health & Wellness Robotic-assist and other tech spark demand in lung cancer surgery market The key developments are led by advances in robotic-assisted surgical systems and imaging technologies Joseph MortonNovember 25, 2024
Medical and Pharmaceutical New Brunswick to use blood testing method for identifying lung cancer This will be the first time that labs in Atlantic Canada utilize liquid biopsies to test for the disease Rowan DunneSeptember 16, 2024